Multiple myeloma is the second most prevalent blood cancer diagnosis in the United States, after non-Hodgkin lymphoma. Males are significantly more likely than females to have multiple myeloma. Myeloma incidence is strongly correlated with age, with the highest rates of diagnosis occurring in adults aged 65 years and older. Approximately 95% of cases are detected at a distant or metastatic stage, with a 5-year relative survival rate of around 53% for this stage. The majority of researchers are unsure of the specific cause of multiple myeloma. They have made progress, however, in understanding how particular alterations in DNA might cause plasma cells to become maligna...
